{
  "timestamp": "2026-02-01T23:06:37.963713",
  "queries": 12,
  "harness_version": "2.0",
  "baseline": {
    "mode": "baseline",
    "timestamp": "2026-02-01T23:11:24.066144",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 22971.75,
    "not_found_rate": 0.25,
    "avg_verified_citations": 3.25,
    "avg_unverified_citations": 0.16666666666666666,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.0,
    "avg_candidates_added": 0.0,
    "avg_phase1_latency_ms": 0.0,
    "avg_answer_length": 4648.833333333333,
    "results": [
      {
        "run_id": "620df35a-caee-4ad3-9757-8422faa92eb3",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769987198_61c20d19",
        "success": true,
        "generated_at": "2026-02-01T23:07:09.113482",
        "final_answer_text": "### Immediate Answer:\nUnder **35 U.S.C. \u00a7 101**, as interpreted by the Supreme Court in *Alice Corp. v. CLS Bank International*, patent eligibility is determined using a two-step framework:\n\n1. **Step 1**: Determine whether the claims at issue are directed to a patent-ineligible concept, such as a law of nature, natural phenomenon, or abstract idea. (([1] *Bilski v. Kappos*) *Universal Secure Registry LLC v. Apple Inc.*), (([2] *Alice Corp. v. CLS Bank International*) *Alice Corp. v. CLS Bank In",
        "answer_length": 6605,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 30350,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769987229_d70e31fc",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769987229_d70e31fc",
        "success": true,
        "generated_at": "2026-02-01T23:08:01.570854",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 51655,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "2822329f-bb33-474b-9a86-929d51b5d772",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769987282_b4362622",
        "success": true,
        "generated_at": "2026-02-01T23:08:24.139758",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis under 35 U.S.C. \u00a7 103 and written description requirements under 35 U.S.C. \u00a7 112, \u00b6 1, differ fundamentally in their focus. Obviousness evaluates whether the claimed invention would have been obvious to a person of ordinary skill in the art at the time of invention, based on prior art. In contrast, the written description requirement ensures that the patent specification demonstrates that the inventor was in possession of the claimed invention as of the ",
        "answer_length": 8007,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 21736,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "a17934b3-d289-4d53-adb9-3cc7f003c5e4",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769987304_d8d0ca7f",
        "success": true,
        "generated_at": "2026-02-01T23:08:37.343125",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct is \"but-for materiality.\" Under this standard, undisclosed prior art or information is considered material if the U.S. Patent and Trademark Office (PTO) would not have allowed a claim had it been aware of the undisclosed information. The court must assess materiality by applying the preponderance of the evidence standard and giving claims their broadest reasonable construction. This standard is explicitly stated in the following excerpt",
        "answer_length": 1464,
        "not_found": false,
        "verified_citations": 1,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 1,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 1,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 12363,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "b177a1cf-e820-492f-b373-38f32375cf70",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769987317_0be1d4d7",
        "success": true,
        "generated_at": "2026-02-01T23:08:55.660690",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations not literally covered by the patent claims. However, prosecution history estoppel limits the application of the doctrine of equivalents when a patentee has narrowed the scope of their claims during prosecution to secure the patent. The Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VIII\"), clarified the relationship between prosecution ",
        "answer_length": 6022,
        "not_found": false,
        "verified_citations": 1,
        "unverified_citations": 2,
        "tier_counts": {
          "STRONG": 1,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 2
        },
        "total_sources": 3,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17489,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "93c9226e-da68-4590-8474-9a14e616b3d0",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769987336_01bdbfee",
        "success": true,
        "generated_at": "2026-02-01T23:09:13.236162",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (pre-AIA) or \u00a7 112(f) (post-AIA) is as follows:\n\n1. **Rebuttable Presumption Based on the Use of the Word \"Means\"**: If a claim term uses the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 applies. Conversely, if the claim term does not use the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 does not apply. However, this presumption ",
        "answer_length": 4816,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 2,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 2,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 16731,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "9956d1b5-d577-4960-ad49-1ff2668b3c97",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769987353_6080532a",
        "success": true,
        "generated_at": "2026-02-01T23:09:28.315621",
        "final_answer_text": "The correct framework for evaluating motivation to combine references is provided by **Graham v. John Deere Co.**, as clarified and expanded upon by **KSR International Co. v. Teleflex Inc.**. Both cases are foundational, but KSR refined the application of the Graham framework, particularly with respect to flexibility and avoiding rigid rules.\n\n## Detailed Analysis:\n\n1. **Graham Framework**:\n   Graham established the foundational framework for determining obviousness under 35 U.S.C. \u00a7 103. It re",
        "answer_length": 5888,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 14248,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769987368_f6737d87",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769987368_f6737d87",
        "success": true,
        "generated_at": "2026-02-01T23:10:01.163103",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: In Re Ferguson, Powerblock Holdings, Inc. v. Ifit, Inc., In Re Bilski\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 255,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 32046,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "f06ef0cf-f6d5-412c-b3e1-f1d33ac37c1e",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769987401_45a87580",
        "success": true,
        "generated_at": "2026-02-01T23:10:31.675969",
        "final_answer_text": "The determination of whether the amount of experimentation required is \"undue\" under the **Wands factors** depends on a case-specific analysis of several factual considerations. The Federal Circuit has consistently emphasized that this is not a single, simple factual determination but rather a conclusion reached by weighing multiple factors. Below is a summary of the relevant principles derived from the provided excerpts:\n\n---\n\n### Immediate Answer:\nThe amount of experimentation is considered \"u",
        "answer_length": 7982,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 29684,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "5b588dcb-545b-4ec5-98bd-255ad7af66b0",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769987432_8c9d2ece",
        "success": true,
        "generated_at": "2026-02-01T23:10:51.785017",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent's specification enables a person of ordinary skill in the art to make and use the full scope of the claimed invention without undue experimentation. This analysis often involves the application of the *Wands* factors, which consider the quantity of experimentation required, the guidance provided in the specification, the presence of working examples, the predictability of the art, and the breadt",
        "answer_length": 6714,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 19271,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "0aaba8ef-1c54-41b3-af51-0a020b5ce5fd",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769987452_220b57f1",
        "success": true,
        "generated_at": "2026-02-01T23:11:11.981168",
        "final_answer_text": "## Immediate Answer:\nEvidence that rebuts a prima facie case of obviousness for combining prior art references includes unexpected results, evidence that the prior art teaches away from the claimed invention, objective indicia of nonobviousness (e.g., commercial success, long-felt but unmet need, failure of others), and evidence that the prior art does not enable the claimed invention. These factors must be considered as part of the totality of evidence before determining obviousness.\n\n## Detail",
        "answer_length": 7492,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 19334,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "05a5bdee-c949-4735-a482-96d125700af1",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769987472_1d16478c",
        "success": true,
        "generated_at": "2026-02-01T23:11:23.565365",
        "final_answer_text": "The provided excerpts do not explicitly address the specific conditions under which an examiner can combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 225,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 10754,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "phase1": {
    "mode": "phase1",
    "timestamp": "2026-02-01T23:17:11.406446",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 28113.916666666668,
    "not_found_rate": 0.3333333333333333,
    "avg_verified_citations": 3.4166666666666665,
    "avg_unverified_citations": 0.08333333333333333,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.6666666666666666,
    "avg_candidates_added": 0.5,
    "avg_phase1_latency_ms": 538.75,
    "avg_answer_length": 4643.75,
    "results": [
      {
        "run_id": "cb3542b3-f30f-4112-89d9-99b0369dc5d5",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769987484_448a0d0b",
        "success": true,
        "generated_at": "2026-02-01T23:12:20.109309",
        "final_answer_text": "### Immediate Answer:\nUnder **35 U.S.C. \u00a7 101**, as interpreted by the Supreme Court in *Alice Corp. v. CLS Bank International*, patent eligibility requires that the claimed invention:\n1. **Not be directed to a patent-ineligible concept** (laws of nature, natural phenomena, or abstract ideas) (Alice Step 1) (([1] *Bilski v. Kappos*) *Universal Secure Registry LLC v. Apple Inc.*), (([2] *Alice Corp. v. CLS Bank International*) *Aatrix Software, Inc. v. Green Shades Software, Inc.*).\n2. **Contain ",
        "answer_length": 7332,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 55710,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 765,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769987540_8d1c678d",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769987540_8d1c678d",
        "success": true,
        "generated_at": "2026-02-01T23:13:02.078071",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 41167,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "e5dea779-856c-4475-a3fd-85679e48ca60",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769987582_338317de",
        "success": true,
        "generated_at": "2026-02-01T23:13:26.100100",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis under 35 U.S.C. \u00a7 103 focuses on whether the claimed invention would have been obvious to a person of ordinary skill in the art at the time of the invention, considering prior art and the level of skill in the field. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1 ensures that the patent specification demonstrates that the inventor was in possession of the claimed invention at the time of filing, particularly by adequately des",
        "answer_length": 8035,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 23189,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 882,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "a79de196-d1ba-42de-b4fc-e224a01a720b",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769987606_1f2a738e",
        "success": true,
        "generated_at": "2026-02-01T23:13:45.315173",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct is \"but-for materiality.\" Under this standard, undisclosed prior art is considered material if the U.S. Patent and Trademark Office (PTO) would not have allowed a claim had it been aware of the undisclosed information. The court must assess materiality by applying the preponderance of the evidence standard and giving the claims their broadest reasonable construction. This standard ensures that only truly significant omissions or misrepr",
        "answer_length": 2967,
        "not_found": false,
        "verified_citations": 4,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 1,
          "MODERATE": 3,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 4,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 18379,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "low_score"
        ],
        "candidates_added": 0,
        "phase1_triggered": true,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "48e27c9c-76a2-4ef0-b4ba-df88f130b15c",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769987625_06cc3731",
        "success": true,
        "generated_at": "2026-02-01T23:14:16.557388",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations to a patented invention that were not literally captured by the patent claims. However, prosecution history estoppel limits the application of the doctrine of equivalents by preventing a patentee from recapturing subject matter surrendered during the prosecution of the patent. After the Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VII",
        "answer_length": 8430,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 30412,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 882,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "32b3706b-1b8f-4119-b079-77911f24d547",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769987657_96b0a976",
        "success": true,
        "generated_at": "2026-02-01T23:14:30.527026",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (pre-AIA) or \u00a7 112(f) (post-AIA) is as follows:\n\n1. **Presumption Based on the Use of \"Means\"**: If the claim term uses the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 applies. Conversely, if the term does not use the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 does not apply. (([1] *WILLIAMSON v. CITRIX ONLINE, LLC*) *Richard",
        "answer_length": 3326,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 2,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 2,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 13123,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1316,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "090f6d80-2eac-48be-b509-d7de8a6f7778",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769987671_f95829fc",
        "success": true,
        "generated_at": "2026-02-01T23:14:45.155046",
        "final_answer_text": "The correct framework for determining motivation to combine references is provided by **Graham v. John Deere Co.**, as clarified and expanded upon by **KSR International Co. v. Teleflex Inc.**. Both cases are foundational, but KSR specifically addresses and refines the application of the motivation-to-combine analysis.\n\n## Detailed Analysis\n\n1. **Graham Framework**:  \n   Graham established the foundational framework for analyzing obviousness under 35 U.S.C. \u00a7 103. It requires courts to consider:",
        "answer_length": 5885,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 13781,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769987685_6bde1362",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769987685_6bde1362",
        "success": true,
        "generated_at": "2026-02-01T23:15:12.478694",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: In Re Ferguson, Powerblock Holdings, Inc. v. Ifit, Inc., In Re Bilski\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 255,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 26522,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "6d7c9d35-b688-4c44-a36f-6f8265d1616c",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769987712_b153eae8",
        "success": true,
        "generated_at": "2026-02-01T23:15:29.965267",
        "final_answer_text": "The amount of experimentation that is considered \"undue\" under the Wands factors for biological claims depends on a case-specific analysis of several factual considerations. The Federal Circuit has consistently emphasized that the determination of undue experimentation is not a single, simple factual determination but rather a conclusion reached by weighing multiple factors. These factors, known as the Wands factors, include:\n\n1. **The quantity of experimentation necessary**  \n2. **The amount of",
        "answer_length": 3681,
        "not_found": false,
        "verified_citations": 0,
        "unverified_citations": 1,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 1
        },
        "total_sources": 1,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 16658,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "low_score"
        ],
        "candidates_added": 0,
        "phase1_triggered": true,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "b94e16de-d829-4e07-bc69-55c8082b3c94",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769987730_8b7af41d",
        "success": true,
        "generated_at": "2026-02-01T23:16:27.225949",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent's specification enables a person of ordinary skill in the art to make and use the full scope of the claimed genus without undue experimentation. This analysis often involves evaluating the breadth of the claims, the guidance provided in the specification, the predictability of the art, and the amount of experimentation required. Below is a detailed explanation based on the provided excerpts:\n\n--",
        "answer_length": 7568,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 56423,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "4257ecf8-9bf1-40f8-8447-c008272d7479",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769987787_b13ea25b",
        "success": true,
        "generated_at": "2026-02-01T23:16:52.415130",
        "final_answer_text": "## Immediate Answer:\nAfter *KSR International Co. v. Teleflex Inc.*, evidence that rebuts a prima facie case of obviousness for combining prior art references includes objective indicia of nonobviousness, such as unexpected results, commercial success, long-felt but unresolved needs, industry skepticism, and failure of others. Additionally, evidence that the prior art teaches away from the claimed invention or that the prior art does not enable the claimed invention can also rebut a prima facie ",
        "answer_length": 7705,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24347,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1191,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "833eb3ef-e665-442c-a207-c5b2ca2becf3",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769987812_666ff8fd",
        "success": true,
        "generated_at": "2026-02-01T23:17:10.905691",
        "final_answer_text": "The provided excerpts do not explicitly address the specific conditions under which an examiner may combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 225,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17656,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1429,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "comparison": {
    "baseline": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 22971.75,
      "not_found_rate": 0.25,
      "avg_verified_citations": 3.25,
      "scotus_coverage": 0.0
    },
    "phase1": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 28113.916666666668,
      "not_found_rate": 0.3333333333333333,
      "avg_verified_citations": 3.4166666666666665,
      "scotus_coverage": 0.0,
      "phase1_trigger_rate": 0.6666666666666666,
      "avg_candidates_added": 0.5
    },
    "deltas": {
      "latency_delta_ms": 5142.166666666668,
      "not_found_delta": 0.08333333333333331,
      "verified_citations_delta": 0.16666666666666652,
      "scotus_coverage_delta": 0.0
    },
    "improvements": {
      "reduced_not_found": false,
      "more_verified_citations": true,
      "better_scotus_coverage": true
    }
  }
}